Terms: = Prostate cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
20 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in prostate Adenocarcinoma.
Zhu J; Zhang J; Hu P; Fan M; Song D; Yin H; Yan P; Xian S; Li Z; Guo J; Long C; Xu R; Huang R; Meng T; Zhang J; Huang Z
Biochem Genet; 2023 Dec; 61(6):2242-2259. PubMed ID: 37010714
[TBL] [Abstract] [Full Text] [Related]
3. MUC Glycoproteins: Potential Biomarkers and Molecular Targets for cancer Therapy.
Ratan C; Cicily K D D; Nair B; Nath LR
Curr Cancer Drug Targets; 2021; 21(2):132-152. PubMed ID: 33200711
[TBL] [Abstract] [Full Text] [Related]
4. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract] [Full Text] [Related]
5. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptome and Proteome Analyses of TNFAIP8 Knockdown cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.
Day TF; Mewani RR; Starr J; Li X; Chakravarty D; Ressom H; Zou X; Eidelman O; Pollard HB; Srivastava M; Kasid UN
Methods Mol Biol; 2017; 1513():83-100. PubMed ID: 27807832
[TBL] [Abstract] [Full Text] [Related]
7. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.
Lichner Z; Ding Q; Samaan S; Saleh C; Nasser A; Al-Haddad S; Samuel JN; Fleshner NE; Stephan C; Jung K; Yousef GM
J Pathol; 2015 Oct; 237(2):226-37. PubMed ID: 26011734
[TBL] [Abstract] [Full Text] [Related]
8. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract] [Full Text] [Related]
9. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
[TBL] [Abstract] [Full Text] [Related]
10. Expression of the adaptor protein Tks5 in human cancer: prognostic potential.
Stylli SS; Luwor RB; Kaye AH; I ST; Hovens CM; Lock P
Oncol Rep; 2014 Sep; 32(3):989-1002. PubMed ID: 24993883
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of steroid receptor coactivator-3 in bone cancers: an in vivo immunohistochemical study with tissue microarray.
Luo F; Li W; Zhang J; Huang K; Fu J; Xie Z
Pathol Res Pract; 2013 Dec; 209(12):790-6. PubMed ID: 24134957
[TBL] [Abstract] [Full Text] [Related]
12. Impact of the src inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells.
Rice L; Lepler S; Pampo C; Siemann DW
Clin Exp Metastasis; 2012 Feb; 29(2):133-42. PubMed ID: 22130962
[TBL] [Abstract] [Full Text] [Related]
13. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract] [Full Text] [Related]
14. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
Rajendran M; Thomes P; Zhang L; Veeramani S; Lin MF
Cancer Metastasis Rev; 2010 Mar; 29(1):207-22. PubMed ID: 20111892
[TBL] [Abstract] [Full Text] [Related]
15. Copine-III interacts with ErbB2 and promotes tumor cell migration.
Heinrich C; Keller C; Boulay A; Vecchi M; Bianchi M; Sack R; Lienhard S; Duss S; Hofsteenge J; Hynes NE
Oncogene; 2010 Mar; 29(11):1598-610. PubMed ID: 20010870
[TBL] [Abstract] [Full Text] [Related]
16. Scatter factor protects tumor cells against apoptosis caused by TRAIL.
Fan S; Meng Q; Laterra JJ; Rosen EM
Anticancer Drugs; 2010 Jan; 21(1):10-24. PubMed ID: 19823077
[TBL] [Abstract] [Full Text] [Related]
17. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.
Alam SM; Rajendran M; Ouyang S; Veeramani S; Zhang L; Lin MF
Endocr Relat Cancer; 2009 Mar; 16(1):1-16. PubMed ID: 19001530
[TBL] [Abstract] [Full Text] [Related]
18. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC; Lo SH
Int J Biochem Cell Biol; 2008; 40(5):843-7. PubMed ID: 17521951
[TBL] [Abstract] [Full Text] [Related]
19. EphrinA1 activates a src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P
J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913
[TBL] [Abstract] [Full Text] [Related]
20. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract] [Full Text] [Related]